ANI Pharmaceuticals Files 8-K on Financials
Ticker: ANIP · Form: 8-K · Filed: Jun 4, 2025 · CIK: 1023024
| Field | Detail |
|---|---|
| Company | Ani Pharmaceuticals Inc (ANIP) |
| Form Type | 8-K |
| Filed Date | Jun 4, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, results-of-operations, disclosure
Related Tickers: ANIP
TL;DR
ANI Pharma dropped an 8-K detailing financial results and other key disclosures.
AI Summary
ANI Pharmaceuticals, Inc. filed an 8-K on June 4, 2025, reporting on its results of operations and financial condition. The filing also includes information regarding Regulation FD disclosures and financial statements and exhibits. The company, incorporated in Delaware, is headquartered in Baudette, Minnesota.
Why It Matters
This 8-K filing provides crucial updates on ANI Pharmaceuticals' financial performance and operational status, which can influence investor decisions.
Risk Assessment
Risk Level: low — This is a routine financial disclosure filing and does not inherently present new risks.
Key Players & Entities
- ANI Pharmaceuticals, Inc. (company) — Registrant
- 210 Main Street West Baudette, Minnesota 56623 (location) — Principal executive offices address
- June 4, 2025 (date) — Date of report
- Delaware (location) — State of incorporation
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on ANI Pharmaceuticals, Inc.'s results of operations and financial condition, as well as to include Regulation FD disclosures and financial statements and exhibits.
When was this 8-K report filed?
This 8-K report was filed on June 4, 2025.
What is the exact name of the company filing this report?
The exact name of the company filing this report is ANI Pharmaceuticals, Inc.
Where is ANI Pharmaceuticals, Inc. headquartered?
ANI Pharmaceuticals, Inc. is headquartered at 210 Main Street West, Baudette, Minnesota 56623.
What is the company's state of incorporation?
The company's state of incorporation is Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 4, 2025 regarding ANI PHARMACEUTICALS INC (ANIP).